Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.65% |
| 2 | Technology | 8.5% |
| 3 | Financials | 8.48% |
| 4 | Consumer Discretionary | 7.65% |
| 5 | Industrials | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Invesco Senior Income Trust
VVR
$456M
| $3.43M | ﹤0.01% |
+800,096
| New | +$3.34M |
|
2202
Barings BDC
BBDC
$869M
| $3.43M | ﹤0.01% |
333,542
-116,168
| -26% | -$1.19M |
|
|
SPNS
2203
DELISTED
Sapiens International
SPNS
| $3.42M | ﹤0.01% |
148,751
-40,327
| -21% | -$872K |
|
|
ZUO
2204
DELISTED
Zuora, Inc.
ZUO
| $3.42M | ﹤0.01% |
238,418
+19,958
| +9% | +$292K |
|
2205
CALL
Biogen
BIIB
$30.9B
| $3.41M | ﹤0.01% |
11,500
-180,000
| -94% | -$49.9M |
|
|
FLIR
2206
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $3.4M | ﹤0.01% |
65,385
+58,760
| +887% | +$3.11M |
|
2207
Teradata
TDC
$2.88B
| $3.4M | ﹤0.01% |
127,158
-442,551
| -78% | -$12.3M |
|
2208
ProQR Therapeutics
PRQR
$244M
| $3.4M | ﹤0.01% |
343,146
+120,567
| +54% | +$939K |
|
|
DHR.PRA
2209
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $3.4M | ﹤0.01% |
2,878
-38
| -1% | -$42.8K |
|
2210
MasterCraft Boat Holdings
MCFT
$596M
| $3.4M | ﹤0.01% |
+215,590
| New | +$3.4M |
|
|
ENLC
2211
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $3.39M | ﹤0.01% |
552,742
+536,803
| +3,368% | +$3.26M |
|
|
KNL
2212
DELISTED
Knoll, Inc.
KNL
| $3.38M | ﹤0.01% |
+133,652
| New | +$3.53M |
|
2213
Fox Class B
FOX
$22.1B
| $3.37M | ﹤0.01% |
92,537
-528,928
| -85% | -$17.8M |
|
|
FARO
2214
DELISTED
Faro Technologies
FARO
| $3.36M | ﹤0.01% |
66,754
+50,146
| +302% | +$2.45M |
|
2215
Cabaletta Bio
CABA
$427M
| $3.35M | ﹤0.01% |
+239,950
| New | +$2.84M |
|
2216
WaFd
WAFD
$2.71B
| $3.35M | ﹤0.01% |
91,330
+41,947
| +85% | +$1.54M |
|
|
FINV
2217
FinVolution Group
FINV
$1.17B
| $3.34M | ﹤0.01% |
1,261,152
-175,891
| -12% | -$466K |
|
2218
Capital City Bank Group
CCBG
$897M
| $3.34M | ﹤0.01% |
109,437
+49,487
| +83% | +$1.43M |
|
|
NGD
2219
DELISTED
New Gold Inc
NGD
| $3.34M | ﹤0.01% |
3,790,381
-3,927,417
| -51% | -$3.55M |
|
|
APLS
2220
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $3.33M | ﹤0.01% |
+108,800
| New | +$3.01M |
|
2221
Endava
DAVA
$165M
| $3.32M | ﹤0.01% |
71,322
-24,016
| -25% | -$1.04M |
|
2222
Upwork
UPWK
$1.18B
| $3.32M | ﹤0.01% |
311,275
+215,675
| +226% | +$2.72M |
|
2223
Cartesian Therapeutics
RNAC
$218M
| $3.32M | ﹤0.01% |
46,443
+37,675
| +430% | +$1.82M |
|
|
ACHN
2224
DELISTED
Achillion Pharmaceuticals
ACHN
| $3.31M | ﹤0.01% |
548,616
-2,739,006
| -83% | -$15.9M |
|
2225
CALL
Analog Devices
ADI
$172B
| $3.3M | ﹤0.01% |
27,800
| – | – |
|
Similar funds
Millennium Management's Q4 2019 Portfolio in Review
As of Q4 2019, Millennium Management held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Millennium Management deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Millennium Management's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Millennium Management's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Millennium Management fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Millennium Management's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Millennium Management opened 829 new positions and closed 796 in Q4 2019.
- Millennium Management's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.